Evidence map›Paper›PMID 28253908›Full record

ArticleMicrobiome2017

Normalization and microbial differential abundance strategies depend upon data characteristics.

Sophie Weiss, Zhenjiang Zech Xu, Shyamal Peddada, Amnon Amir, Kyle Bittinger, Antonio Gonzalez, Catherine Lozupone, Jesse R Zaneveld, Yoshiki Vázquez-Baeza, Amanda Birmingham and 2 more

Abstract read
In one paragraph

Article in Microbiome, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,028 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,028citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,028 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Assessing the Impact ofNutrients · 2026
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Effects ofMicroorganisms · 2026
    Article
  20. Article

968 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sophie WeissDepartment of Chemical and Biological Engineering, University of Colorado at Boulder, Boulder, CO, 80309, USA.
Zhenjiang Zech XuDepartments of Pediatrics, University of California San Diego, 9500 Gilman Drive, MC 0763, La Jolla, CA, 92093, USA.
Shyamal PeddadaBiostatistics and Computational Biology Branch, NIEHS, NIH, Research Triangle Park Durham, NC, USA.
Amnon AmirDepartments of Pediatrics, University of California San Diego, 9500 Gilman Drive, MC 0763, La Jolla, CA, 92093, USA.
Kyle BittingerDepartment of Microbiology, University of Pennsylvania, Philadelphia, PA, 18014, USA.
Antonio GonzalezDepartments of Pediatrics, University of California San Diego, 9500 Gilman Drive, MC 0763, La Jolla, CA, 92093, USA.
Catherine LozuponeDepartment of Medicine, University of Colorado, Denver, CO, 80204, USA.
Jesse R ZaneveldDepartment of Microbiology, Oregon State University, 226 Nash Hall, Corvallis, OR, 97331, USA.
Yoshiki Vázquez-BaezaDepartment of Computer Science & Engineering, University of California San Diego, La Jolla, CA, 92093, USA.
Amanda BirminghamCenter for Computational Biology and Bioinformatics, Dept. of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Embriette R HydeDepartments of Pediatrics, University of California San Diego, 9500 Gilman Drive, MC 0763, La Jolla, CA, 92093, USA.
Rob KnightDepartments of Pediatrics, University of California San Diego, 9500 Gilman Drive, MC 0763, La Jolla, CA, 92093, USA. robknight@ucsd.edu.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
A Quality Assurance, Coordination and Analysis Center for HMPU01HG004866 · NHGRI · UNIVERSITY OF MARYLAND BALTIMORE · PI WHITE, OWEN R · 2008 to 2012
$12.5M
Statistical Methods with Applications to Toxicology and Microarray dataZIAES101744 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI PEDDADA, SHYAMAL · 2009 to 2017
$4.2M
New Tools for Understanding the Composition and Dynamics of Microbial CommunitiesR01HG004872 · NHGRI · UNIVERSITY OF COLORADO · PI KNIGHT, ROB · 2008 to 2012
$1.8M
Statistical Theory and Methodology with Applications toZ01ES101744 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI PEDDADA, SHYAMAL · 2004 to 2008
$803k
Intramural NIH HHS Z01 ES101744NCATS NIH HHS UL1 TR001442NHGRI NIH HHS R01 HG004872NHGRI NIH HHS U01 HG004866
6 · The paper itself

Abstract

backgroundData from 16S ribosomal RNA (rRNA) amplicon sequencing present challenges to ecological and statistical interpretation. In particular, library sizes often vary over several ranges of magnitude, and the data contains many zeros. Although we are typically interested in comparing relative abundance of taxa in the ecosystem of two or more groups, we can only measure the taxon relative abundance in specimens obtained from the ecosystems. Because the comparison of taxon relative abundance in the specimen is not equivalent to the comparison of taxon relative abundance in the ecosystems, this presents a special challenge. Second, because the relative abundance of taxa in the specimen (as well as in the ecosystem) sum to 1, these are compositional data. Because the compositional data are constrained by the simplex (sum to 1) and are not unconstrained in the Euclidean space, many standard methods of analysis are not applicable. Here, we evaluate how these challenges impact the performance of existing normalization methods and differential abundance analyses.

resultsEffects on normalization: Most normalization methods enable successful clustering of samples according to biological origin when the groups differ substantially in their overall microbial composition. Rarefying more clearly clusters samples according to biological origin than other normalization techniques do for ordination metrics based on presence or absence. Alternate normalization measures are potentially vulnerable to artifacts due to library size. Effects on differential abundance testing: We build on a previous work to evaluate seven proposed statistical methods using rarefied as well as raw data. Our simulation studies suggest that the false discovery rates of many differential abundance-testing methods are not increased by rarefying itself, although of course rarefying results in a loss of sensitivity due to elimination of a portion of available data. For groups with large (~10×) differences in the average library size, rarefying lowers the false discovery rate. DESeq2, without addition of a constant, increased sensitivity on smaller datasets (<20 samples per group) but tends towards a higher false discovery rate with more samples, very uneven (~10×) library sizes, and/or compositional effects. For drawing inferences regarding taxon abundance in the ecosystem, analysis of composition of microbiomes (ANCOM) is not only very sensitive (for >20 samples per group) but also critically the only method tested that has a good control of false discovery rate.

conclusionsThese findings guide which normalization and differential abundance techniques to use based on the data characteristics of a given study.

Indexed as

BacteriaBacterial LoadBase SequenceDNA, BacterialEcosystemGene LibraryHumansMicrobial ConsortiaRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialRNA, Ribosomal, 16SDifferential abundanceMicrobiomeNormalizationStatistics

Identifiers

PMID28253908
PMCPMC5335496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.